NCT01409616View on ClinicalTrials.gov

To Evaluate Whether Acetyl Salicylic Acid (Aspirin), the Combination of Aspirin and Clopidogrel and Darexaban (YM150) Interact in Their Effects

PHASE1CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions
Pharmacodynamic InteractionHealthy Subjects
Interventions
DRUG

darexaban

oral

DRUG

darexaban (double dose)

oral

DRUG

Acetyl Salicylic Acid

oral

DRUG

clopidogrel

oral

Trial Locations (1)

75015

SGS Aster, Paris

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY